French multinational pharmaceutical company Sanofi has agreed to purchase U.S. biotech company Principia Biopharma Inc. for about $3.4 billion in an all-cash deal. As part of the deal, Sanofi will be taking full control of the company, which focuses on treatments for multiple sclerosis and a range of autoimmune disorders. Sanofi will secure drugs such … Continue reading “Sanofi Agrees to Buy Principia Biopharma Inc. for Roughly $3.4 Billion”
Tag: multiple sclerosis
Biotech & Pharma
The FDA Just Approved The First Drug For Aggressive Multiple Sclerosis
Genentech had some great news this week as the Food and Drug Administration has approved…
March 29, 2017
Biotech & Pharma
This New Vaccine Could Treat Multiple Sclerosis
Multiple Sclerosis is one of the most severe diseases in the neurodegenartive autoimmune family. Protective…
June 27, 2016